Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

Enocsson, Helena; Wirestam, Lina; Dahle, Charlotte; Padyukov, Leonid; Jonsen, Andreas; Urowitz, Murray; Gladmane, Dafna; ROMERO-DIAZ, Juanita; BAE, Sang-Cheol; Fortin, Paul; Sanchez-Guerrero, Jorge; Clarke, Ann; Bernatsky, Sasha; Gordon, Caroline; HANLY, John; WALLACE, Daniel; Isenberg, David; Rahman, Anisur; MERRILL, Joan; GINZLER, Ellen; ALARCON, Graciela; CHATHAM, W.; Petri, Michelle; KHAMASHTA, Munther; ARANOW, Cynthia; MACKAY, Meggan; Dooley, Mary; MANZI, Susan; Ramsey-Goldman, Rosalind; Nived, Ola; STEINSSON, Kristjan; ZOMA, Asad; RUIZ-IRASTORZA, Guillermo; Lim, S.; KALUNIAN, Kenneth; Inanc, Murat; VAN VOLLENHOVEN, Ronald; RAMOS-CASALS, Manuel; KAMEN, Diane; JACOBSEN, Soren; Peschken, Christine; Askanase, Anca; STOLL, Thomas; Bruce, Ian; Wettero, Jonas; Sjowall, Christopher

doi:10.1016/j.jaut.2019.102340

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

Atıf İçin Kopyala

Enocsson H., Wirestam L., Dahle C., Padyukov L., Jonsen A., Urowitz M. B. , ...Daha Fazla

JOURNAL OF AUTOIMMUNITY, cilt.106, 2020 (SCI İndekslerine Giren Dergi)

Cilt numarası: 106
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.jaut.2019.102340
Dergi Adı: JOURNAL OF AUTOIMMUNITY

Özet

Objective: The soluble urokinase plasminogen activator receptor (suPAR) has potential as a prognosis and severity biomarker in several inflammatory and infectious diseases. In a previous cross-sectional study, suPAR levels were shown to reflect damage accrual in cases of systemic lupus erythematosus (SLE). Herein, we evaluated suPAR as a predictor of future organ damage in recent-onset SLE.